Literature DB >> 28454988

Physicians' Perceptions of Factors Influencing the Treatment Decision-making Process for Men With Low-risk Prostate Cancer.

Kimberly Davis1, Paula Bellini2, Charlotte Hagerman2, Riley Zinar2, Daniel Leigh2, Richard Hoffman3, David Aaronson4, Stephen Van Den Eeden5, George Philips6, Kathryn Taylor2.   

Abstract

OBJECTIVE: To assess physicians' attitudes regarding multiple factors that may influence recommendations for active surveillance (AS) vs active treatment (AT) given the central role physicians play in the treatment decision-making process.
MATERIALS AND METHODS: We conducted semistructured interviews to assess factors that physicians consider important when recommending AS vs AT, as well as physicians' perceptions of what their patients consider important in the decision. Participants included urologists (N = 11), radiation oncologists (N = 12), and primary care physicians (N = 10) from both integrated and fee-for-service healthcare settings.
RESULTS: Across the specialties, quantitative data indicated that most physicians reported that their recommendations for AS were influenced by patients' older age, willingness and ability to follow a surveillance protocol, anxiety, comorbidities, life expectancy, and treatment preferences. Qualitative findings highlighted physicians' concerns about malpractice lawsuits, given the possibility of disease progression. Additionally, most physicians noted the role of the healthcare setting, suggesting that financial incentives may be associated with AT recommendations in fee-for-service settings. Finally, most physicians reported spouse or family opposition to AS due to their own anxiety or lack of understanding of AS.
CONCLUSION: We found that patient and physician preferences, healthcare setting, and family or spouse factors influence physicians' treatment recommendations for men with low-risk PCa. These were consistent themes across physician subspecialties in both an Health Maintenance Organization and in fee-for-service settings.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2017        PMID: 28454988      PMCID: PMC5880528          DOI: 10.1016/j.urology.2017.02.056

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  29 in total

1.  Multiple physician recommendations for prostate cancer treatment: a Pandora's box for patients?

Authors:  Willie Underwood; Heather Orom; Michael Poch; Brady T West; Paula M Lantz; Sam S Chang; Jay H Fowke
Journal:  Can J Urol       Date:  2010-10       Impact factor: 1.344

2.  Guideline for the management of clinically localized prostate cancer: 2007 update.

Authors:  Ian Thompson; James Brantley Thrasher; Gunnar Aus; Arthur L Burnett; Edith D Canby-Hagino; Michael S Cookson; Anthony V D'Amico; Roger R Dmochowski; David T Eton; Jeffrey D Forman; S Larry Goldenberg; Javier Hernandez; Celestia S Higano; Stephen R Kraus; Judd W Moul; Catherine M Tangen
Journal:  J Urol       Date:  2007-06       Impact factor: 7.450

3.  Decision-making processes among men with low-risk prostate cancer: A survey study.

Authors:  Richard M Hoffman; Stephen K Van Den Eeden; Kimberly M Davis; Tania Lobo; George Luta; Jun Shan; David Aaronson; David F Penson; Amethyst D Leimpeter; Kathryn L Taylor
Journal:  Psychooncology       Date:  2017-07-13       Impact factor: 3.894

4.  NCCN clinical practice guidelines in oncology: prostate cancer.

Authors:  James Mohler; Robert R Bahnson; Barry Boston; J Erik Busby; Anthony D'Amico; James A Eastham; Charles A Enke; Daniel George; Eric Mark Horwitz; Robert P Huben; Philip Kantoff; Mark Kawachi; Michael Kuettel; Paul H Lange; Gary Macvicar; Elizabeth R Plimack; Julio M Pow-Sang; Mack Roach; Eric Rohren; Bruce J Roth; Dennis C Shrieve; Matthew R Smith; Sandy Srinivas; Przemyslaw Twardowski; Patrick C Walsh
Journal:  J Natl Compr Canc Netw       Date:  2010-02       Impact factor: 11.908

5.  A multi-institutional evaluation of active surveillance for low risk prostate cancer.

Authors:  Scott E Eggener; Alex Mueller; Ryan K Berglund; Raj Ayyathurai; Cindy Soloway; Mark S Soloway; Robert Abouassaly; Eric A Klein; Steven J Jones; Chris Zappavigna; Larry Goldenberg; Peter T Scardino; James A Eastham; Bertrand Guillonneau
Journal:  J Urol       Date:  2013-01       Impact factor: 7.450

6.  Factors that influence patient enrollment in active surveillance for low-risk prostate cancer.

Authors:  Michael A Gorin; Cynthia T Soloway; Ahmed Eldefrawy; Mark S Soloway
Journal:  Urology       Date:  2011-01-07       Impact factor: 2.649

Review 7.  Active surveillance for prostate cancer: a systematic review of the literature.

Authors:  Marc A Dall'Era; Peter C Albertsen; Christopher Bangma; Peter R Carroll; H Ballentine Carter; Matthew R Cooperberg; Stephen J Freedland; Laurence H Klotz; Christopher Parker; Mark S Soloway
Journal:  Eur Urol       Date:  2012-06-07       Impact factor: 20.096

8.  Time trends and local variation in primary treatment of localized prostate cancer.

Authors:  Matthew R Cooperberg; Jeanette M Broering; Peter R Carroll
Journal:  J Clin Oncol       Date:  2010-02-01       Impact factor: 44.544

Review 9.  Patient decision aids for prostate cancer treatment: a systematic review of the literature.

Authors:  Grace A Lin; David S Aaronson; Sara J Knight; Peter R Carroll; R Adams Dudley
Journal:  CA Cancer J Clin       Date:  2009-10-19       Impact factor: 508.702

10.  The impact of PSA screening on prostate cancer mortality and overdiagnosis of prostate cancer in the United States.

Authors:  Bret T Howrey; Yong-Fang Kuo; Yu-Li Lin; James S Goodwin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-05-04       Impact factor: 6.053

View more
  4 in total

1.  Influence of Men's Personality and Social Support on Treatment Decision-Making for Localized Prostate Cancer.

Authors:  Elyse Reamer; Felix Yang; Margaret Holmes-Rovner; Joe Liu; Jinping Xu
Journal:  Biomed Res Int       Date:  2017-07-12       Impact factor: 3.411

Review 2.  Quality of life in active surveillance and the associations with decision-making-a literature review.

Authors:  Julia Menichetti; Riccardo Valdagni; Lara Bellardita
Journal:  Transl Androl Urol       Date:  2018-02

3.  Patient Factors That Influence How Physicians Discuss Active Surveillance With Low-Risk Prostate Cancer Patients: A Qualitative Study.

Authors:  Joanna Veazey Brooks; Shellie D Ellis; Emily Morrow; Kim S Kimminau; J Brantley Thrasher
Journal:  Am J Mens Health       Date:  2018-07-04

Review 4.  Multi-disciplinary and shared decision-making approach in the management of organ-confined prostate cancer.

Authors:  Syed M Nazim; Mohamed Fawzy; Christian Bach; M Hammad Ather
Journal:  Arab J Urol       Date:  2018-08-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.